US Stock MarketDetailed Quotes

Stoke Therapeutics (STOK)

Watchlist
  • 28.990
  • -0.290-0.99%
Trading Jan 16 14:47 ET
1.66BMarket Cap42.63P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Stoke Therapeutics (STOK) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-40.49%-30.37M
-45.46%-25.42M
636.62%131.83M
-7.13%-86.85M
-12.33%-23.19M
-25.21%-21.62M
19.83%-17.48M
-15.03%-24.57M
-154.40%-81.07M
7.71%-20.65M
Net income from continuing operations
-45.09%-38.35M
8.61%-23.48M
527.99%112.88M
15.01%-88.98M
61.12%-10.48M
-7.69%-26.43M
16.18%-25.7M
-16.98%-26.37M
-3.59%-104.7M
-5.08%-26.96M
Operating gains losses
----
----
----
----
----
----
----
----
--1K
----
Depreciation and amortization
-18.15%442K
-18.61%446K
-15.28%477K
-11.83%2.18M
-15.71%526K
-15.23%540K
-10.31%548K
-5.70%563K
59.70%2.47M
2.46%624K
Other non cash items
-4.20%547K
8.90%612K
8.91%599K
0.22%2.27M
-1.36%582K
1.24%571K
1.08%562K
0.00%550K
13.62%2.26M
8.66%590K
Change In working capital
65.49%-1.12M
-36,976.67%-11.12M
347.56%11.61M
-366.67%-28.14M
-2,205.83%-20.18M
-823.93%-3.24M
-102.80%-30K
20.18%-4.69M
-114.02%-6.03M
75.06%-875K
-Change in prepaid assets
494.94%5.64M
-497.83%-3.85M
-632.09%-2.56M
-447.07%-1.84M
-232.37%-1.79M
284.44%948K
-136.22%-644K
83.29%-349K
110.21%529K
188.55%1.35M
-Change in payables and accrued expense
751.67%4.88M
-22.70%2.77M
347.06%4.74M
196.26%3.09M
289.64%2.18M
-137.13%-749K
180.80%3.58M
-646.72%-1.92M
9.12%-3.21M
-677.39%-1.15M
-Change in other working capital
-31.22%-4.06M
-238.78%-10.04M
489.06%9.43M
-777.11%-29.39M
-1,838.09%-20.91M
-66.88%-3.09M
-179.61%-2.96M
41.47%-2.42M
-106.48%-3.35M
50.50%-1.08M
Cash from discontinued investing activities
Operating cash flow
-40.49%-30.37M
-45.46%-25.42M
636.62%131.83M
-7.13%-86.85M
-12.32%-23.19M
-25.22%-21.62M
19.83%-17.48M
-15.03%-24.57M
-154.40%-81.07M
7.71%-20.65M
Investing cash flow
Cash flow from continuing investing activities
130.31%9.09M
-68.19%-148.48M
36.48%13.63M
-201.44%-107.48M
-94.46%819K
-305.27%-30M
-476.08%-88.28M
-81.18%9.99M
330.91%105.95M
-34.32%14.77M
Net PPE purchase and sale
-28.16%-132K
-234.78%-154K
-1,166.67%-152K
87.44%-203K
81.66%-42K
73.11%-103K
94.52%-46K
92.73%-12K
59.21%-1.62M
44.01%-229K
Net investment purchase and sale
130.86%9.23M
-68.11%-148.32M
37.84%13.78M
-199.73%-107.27M
-94.26%861K
-299.34%-29.9M
-462.92%-88.23M
-81.22%10M
356.59%107.56M
-34.49%15M
Cash from discontinued investing activities
Investing cash flow
130.31%9.09M
-68.19%-148.48M
36.48%13.63M
-201.44%-107.48M
-94.46%819K
-305.27%-30M
-476.08%-88.28M
-81.18%9.99M
330.91%105.95M
-34.32%14.77M
Financing cash flow
Cash flow from continuing financing activities
-61.76%3.12M
-99.54%554K
-19.98%1.37M
147.31%131.09M
-92.26%568K
1,351.78%8.16M
251,254.17%120.65M
-96.19%1.72M
14.22%53.01M
16,976.74%7.34M
Net common stock issuance
--0
--0
--0
147.38%128.84M
-99.99%1K
--7.66M
--119.88M
-97.10%1.3M
14.86%52.08M
--7.34M
Proceeds from stock option exercised by employees
520.28%3.12M
-27.68%554K
228.71%1.37M
143.41%2.25M
11,240.00%567K
-10.50%503K
1,495.83%766K
34.41%418K
-12.97%926K
-88.10%5K
Cash from discontinued financing activities
Financing cash flow
-61.76%3.12M
-99.54%554K
-19.98%1.37M
147.31%131.09M
-92.26%568K
1,351.78%8.16M
251,254.17%120.65M
-96.19%1.72M
14.22%53.01M
16,976.74%7.34M
Net cash flow
Beginning cash position
-47.30%102.27M
53.84%275.61M
-32.93%128.78M
68.25%192.01M
-20.97%150.59M
0.74%194.05M
-6.16%179.15M
68.25%192.01M
-21.54%114.13M
67.20%190.55M
Current changes in cash
58.23%-18.15M
-1,263.78%-173.35M
1,241.69%146.83M
-181.19%-63.23M
-1,588.46%-21.81M
-1,986.41%-43.46M
765.49%14.9M
-116.75%-12.86M
348.53%77.89M
815.63%1.47M
End cash Position
-44.14%84.12M
-47.30%102.27M
53.84%275.61M
-32.93%128.78M
-32.93%128.78M
-20.97%150.59M
0.74%194.05M
-6.16%179.15M
68.25%192.01M
68.25%192.01M
Free cash flow
-40.43%-30.5M
-45.96%-25.58M
635.74%131.68M
-5.29%-87.05M
-11.29%-23.24M
-23.08%-21.72M
22.60%-17.52M
-14.20%-24.58M
-130.78%-82.68M
8.36%-20.88M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -40.49%-30.37M-45.46%-25.42M636.62%131.83M-7.13%-86.85M-12.33%-23.19M-25.21%-21.62M19.83%-17.48M-15.03%-24.57M-154.40%-81.07M7.71%-20.65M
Net income from continuing operations -45.09%-38.35M8.61%-23.48M527.99%112.88M15.01%-88.98M61.12%-10.48M-7.69%-26.43M16.18%-25.7M-16.98%-26.37M-3.59%-104.7M-5.08%-26.96M
Operating gains losses ----------------------------------1K----
Depreciation and amortization -18.15%442K-18.61%446K-15.28%477K-11.83%2.18M-15.71%526K-15.23%540K-10.31%548K-5.70%563K59.70%2.47M2.46%624K
Other non cash items -4.20%547K8.90%612K8.91%599K0.22%2.27M-1.36%582K1.24%571K1.08%562K0.00%550K13.62%2.26M8.66%590K
Change In working capital 65.49%-1.12M-36,976.67%-11.12M347.56%11.61M-366.67%-28.14M-2,205.83%-20.18M-823.93%-3.24M-102.80%-30K20.18%-4.69M-114.02%-6.03M75.06%-875K
-Change in prepaid assets 494.94%5.64M-497.83%-3.85M-632.09%-2.56M-447.07%-1.84M-232.37%-1.79M284.44%948K-136.22%-644K83.29%-349K110.21%529K188.55%1.35M
-Change in payables and accrued expense 751.67%4.88M-22.70%2.77M347.06%4.74M196.26%3.09M289.64%2.18M-137.13%-749K180.80%3.58M-646.72%-1.92M9.12%-3.21M-677.39%-1.15M
-Change in other working capital -31.22%-4.06M-238.78%-10.04M489.06%9.43M-777.11%-29.39M-1,838.09%-20.91M-66.88%-3.09M-179.61%-2.96M41.47%-2.42M-106.48%-3.35M50.50%-1.08M
Cash from discontinued investing activities
Operating cash flow -40.49%-30.37M-45.46%-25.42M636.62%131.83M-7.13%-86.85M-12.32%-23.19M-25.22%-21.62M19.83%-17.48M-15.03%-24.57M-154.40%-81.07M7.71%-20.65M
Investing cash flow
Cash flow from continuing investing activities 130.31%9.09M-68.19%-148.48M36.48%13.63M-201.44%-107.48M-94.46%819K-305.27%-30M-476.08%-88.28M-81.18%9.99M330.91%105.95M-34.32%14.77M
Net PPE purchase and sale -28.16%-132K-234.78%-154K-1,166.67%-152K87.44%-203K81.66%-42K73.11%-103K94.52%-46K92.73%-12K59.21%-1.62M44.01%-229K
Net investment purchase and sale 130.86%9.23M-68.11%-148.32M37.84%13.78M-199.73%-107.27M-94.26%861K-299.34%-29.9M-462.92%-88.23M-81.22%10M356.59%107.56M-34.49%15M
Cash from discontinued investing activities
Investing cash flow 130.31%9.09M-68.19%-148.48M36.48%13.63M-201.44%-107.48M-94.46%819K-305.27%-30M-476.08%-88.28M-81.18%9.99M330.91%105.95M-34.32%14.77M
Financing cash flow
Cash flow from continuing financing activities -61.76%3.12M-99.54%554K-19.98%1.37M147.31%131.09M-92.26%568K1,351.78%8.16M251,254.17%120.65M-96.19%1.72M14.22%53.01M16,976.74%7.34M
Net common stock issuance --0--0--0147.38%128.84M-99.99%1K--7.66M--119.88M-97.10%1.3M14.86%52.08M--7.34M
Proceeds from stock option exercised by employees 520.28%3.12M-27.68%554K228.71%1.37M143.41%2.25M11,240.00%567K-10.50%503K1,495.83%766K34.41%418K-12.97%926K-88.10%5K
Cash from discontinued financing activities
Financing cash flow -61.76%3.12M-99.54%554K-19.98%1.37M147.31%131.09M-92.26%568K1,351.78%8.16M251,254.17%120.65M-96.19%1.72M14.22%53.01M16,976.74%7.34M
Net cash flow
Beginning cash position -47.30%102.27M53.84%275.61M-32.93%128.78M68.25%192.01M-20.97%150.59M0.74%194.05M-6.16%179.15M68.25%192.01M-21.54%114.13M67.20%190.55M
Current changes in cash 58.23%-18.15M-1,263.78%-173.35M1,241.69%146.83M-181.19%-63.23M-1,588.46%-21.81M-1,986.41%-43.46M765.49%14.9M-116.75%-12.86M348.53%77.89M815.63%1.47M
End cash Position -44.14%84.12M-47.30%102.27M53.84%275.61M-32.93%128.78M-32.93%128.78M-20.97%150.59M0.74%194.05M-6.16%179.15M68.25%192.01M68.25%192.01M
Free cash flow -40.43%-30.5M-45.96%-25.58M635.74%131.68M-5.29%-87.05M-11.29%-23.24M-23.08%-21.72M22.60%-17.52M-14.20%-24.58M-130.78%-82.68M8.36%-20.88M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +4.28%
Sample Name
Sample Code
 +3.22%
Sample Name
Sample Code
 +2.53%
4
Block
XYZ
+1.49%
5
Microsoft
MSFT
+1.26%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +10.66%
Sample Name
Sample Code
 +10.40%
Sample Name
Sample Code
 +9.92%
4
Kingsoft Cloud
KC
+6.85%
5
United Microelectronics
UMC
+6.37%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -